SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (428)1/17/1999 4:51:00 PM
From: scaram(o)uche  Read Replies (1) of 1073
 
David:

Certainly not puffery. They've been working on PEG forever. They used to champion the induction of tolerance and avoidance of immune responses using PEGylation, based on the work of a guy who IMO was only telling part of the story. I therefore didn't like them.

However, they have worked the half-life issue consistently and it appears to be validated by work with epo variants by AMGN.

That's about all the help I can be. What else are they doing? Not certain that they fit this thread at a price:book of 22, but.... what the heck.

Thanks.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News